122 related articles for article (PubMed ID: 36870401)
1. Comparison of in vivo behaviors of intramuscularly long-acting celecoxib nanosuspensions with different particle sizes for the postoperative pain treatment.
Qin M; Ye G; Xin J; Li M; Sui X; Sun Y; Fu Q; He Z
Int J Pharm; 2023 Apr; 636():122793. PubMed ID: 36870401
[TBL] [Abstract][Full Text] [Related]
2. Stabilizer-induced different in vivo behaviors for intramuscularly long-acting celecoxib nanocrystals.
Qin M; Xin J; Han W; Li M; Sui X; Dong H; Fu Q; He Z
Int J Pharm; 2022 Nov; 628():122298. PubMed ID: 36257466
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process.
Jeong SC; Kim DS; Jin SG; Youn YS; Oh KT; Li DX; Yong CS; Oh Kim J; Kim KS; Choi HG
Pharmazie; 2018 Sep; 73(9):498-502. PubMed ID: 30223931
[TBL] [Abstract][Full Text] [Related]
4. The role of potassium channel activation in celecoxib-induced analgesic action.
Mi Y; Zhang X; Zhang F; Qi J; Gao H; Huang D; Li L; Zhang H; Du X
PLoS One; 2013; 8(1):e54797. PubMed ID: 23358696
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
6. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
Patlolla RR; Chougule M; Patel AR; Jackson T; Tata PN; Singh M
J Control Release; 2010 Jun; 144(2):233-41. PubMed ID: 20153385
[TBL] [Abstract][Full Text] [Related]
7. Employment of Alginate Floating
Abdul Rasool BK; Khalifa A; Abu-Gharbieh E; Khan R
Biomed Res Int; 2020; 2020():1879125. PubMed ID: 32596281
[TBL] [Abstract][Full Text] [Related]
8. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.
Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y
Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037
[TBL] [Abstract][Full Text] [Related]
9. Development and Evaluation of a Reconstitutable Dry Suspension to Improve the Dissolution and Oral Absorption of Poorly Water-Soluble Celecoxib.
Kim HI; Park SY; Park SJ; Lee J; Cho KH; Jee JP; Kim HC; Maeng HJ; Jang DJ
Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30158472
[TBL] [Abstract][Full Text] [Related]
10. Effect of
More SJ; Tandulwadkar SS; Balap AR; Lohidasan S; Sinnathambi A; Mahadik KR
Futur J Pharm Sci; 2023; 9(1):1. PubMed ID: 36620352
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats.
Nirbhavane P; Sharma G; Singh B; Khuller GK; Goni VG; Patil AB; Katare OP
AAPS PharmSciTech; 2018 Oct; 19(7):3187-3198. PubMed ID: 30143947
[TBL] [Abstract][Full Text] [Related]
12. An in situ forming gel co-loaded with pirarubicin and celecoxib inhibits postoperative recurrence and metastasis of breast cancer.
Wu M; Zhang W; Zhou X; Wang Z; Li S; Guo C; Yang Y; Zhang R; Zhang Z; Sun X; Gong T
Int J Pharm; 2024 Mar; 653():123897. PubMed ID: 38360289
[TBL] [Abstract][Full Text] [Related]
13. DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect.
Alonso-González M; Fernández-Carballido A; Quispe-Chauca P; Lozza I; Martín-Sabroso C; Isabel Fraguas-Sánchez A
Eur J Pharm Biopharm; 2022 Nov; 180():149-160. PubMed ID: 36220520
[TBL] [Abstract][Full Text] [Related]
14. Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.
Desai PR; Shah PP; Patlolla RR; Singh M
Pharm Res; 2012 Sep; 29(9):2587-600. PubMed ID: 22644591
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.
Jeon D; Kim KT; Baek MJ; Kim DH; Lee JY; Kim DD
Eur J Pharm Biopharm; 2019 Aug; 141():139-148. PubMed ID: 31150807
[TBL] [Abstract][Full Text] [Related]
16. New celecoxib multiparticulate systems to improve glioblastoma treatment.
Vera M; Barcia E; Negro S; Marcianes P; García-García L; Slowing K; Fernández-Carballido A
Int J Pharm; 2014 Oct; 473(1-2):518-27. PubMed ID: 25066075
[TBL] [Abstract][Full Text] [Related]
17. Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.
Moore RA; Derry S; Aldington D; Wiffen PJ
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD008659. PubMed ID: 26414123
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of crystallization and growth of celecoxib nanoparticles formed from volatile microemulsions.
Margulis-Goshen K; Weitman M; Major DT; Magdassi S
J Pharm Sci; 2011 Oct; 100(10):4390-400. PubMed ID: 21630277
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation.
Arslan A; Yet B; Nemutlu E; Akdağ Çaylı Y; Eroğlu H; Öner L
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839685
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment.
Wang Q; Yang X; Gu X; Wei F; Cao W; Zheng L; Li Y; Ma T; Wu C; Wang Q
Int J Pharm; 2022 Sep; 625():122108. PubMed ID: 35970280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
